HIV Drug Patents in China – A Patent Landscape
This report focuses on the HIV drug patent landscape in China. The patents included this landscape include key ARV patents that are likely to have a bearing on procurement decisions in China.
India and Second-Line ART, Evaluating the Way Forward, INP+ Discussion Paper
This discussion paper was commissioned by the Indian Network for People Living with HIV/AIDS (INP+) to address the feasibility of introducing second-line ART into NACO’s public-sector treatment programme.
Voluntary Licensing Practices in the Pharmaceutical Sector: An Acceptable Solution to Improving Access to Affordable Medicines?
Tahir Amin, Oxfam
Urgent Need for Second-Line HIV Treatment
Radhakrishnan and Abraham, Indian Medical Parliamentarians Forum
1
2